RTC
TECH icon

Riverview Trust Company’s Bio-Techne TECH Stock Holding History

Riverview Trust Company’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$576 – 802
2024
Q4 		$576 Hold
8
– – ﹤0.01% 760
2024
Q3 		$639 Buy
+8
New +$601 ﹤0.01% 740
2023
Q4 		– Sell
-286
Closed -$19.5K – 574
2023
Q3 		$19.5K Buy
286
+122
+74% +$9.64K 0.02% 394
2023
Q2 		$13.4K Hold
164
– – 0.01% 609
2023
Q1 		$12.2K Hold
164
– – 0.01% 632
2022
Q4 		$14K Buy
+164
New +$13K 0.01% 520
2022
Q2 		– Sell
-200
Closed -$22K – 856
2022
Q1 		$22K Buy
+200
New +$20.6K 0.02% 461

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Riverview Trust Company's TECH Position: Q1 2025 in Review

Riverview Trust Company sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 8 shares — an estimated $576 sold.

Riverview Trust Company first reported a position in TECH in Q1 2022 and held it in 7 quarters. The position peaked at $22K in Q1 2022. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Riverview Trust Company reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 8 Bio-Techne shares in Q1 2025, an estimated $576.
  • Riverview Trust Company first reported a position in Bio-Techne in Q1 2022 and held it in 7 quarters.
  • Riverview Trust Company's Bio-Techne position peaked at $22K in Q1 2022.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.